Drug Discovery Looks for Its Next Fix

By Michael Feldman

July 31, 2012

Despite the highly profitable nature of the pharmaceutical business and the large amount of R&D money companies throw at creating new medicines, the pace of drug development is agonizingly slow.  Over the last few years, on average, less than two dozen new drugs have been introduced per year. One of the more promising technologies that could help speed up this process is supercomputing, which can be used not only to find better, safer drugs, but also to weed out those compounds that would eventually fail during the latter stages of drug trials.

According to a 2010 report in Nature, big pharma spends something like $50 billion per year on drug research and development. (To put that in perspective, that’s four to five times the total spend for high performance computing.) The Nature report estimates the price tag to bring a drug successfully to market is about $1.8 billion, and rising. A lot of that cost is due to the high attrition rate of drugs, which is caused by problems in absorption, distribution, metabolism, excretion and toxicity that gets uncovered during clinical trials.

Ideally, the drug makers would like know which compounds were going to succeed before they got to the expensive stages of development. That’s where high performance computing can help. The approach is to use molecular docking simulations on the computer to determine if the drug candidate can bind to the target protein associated with the disease. The general idea is to find the key (the small molecule drug) that fits in the lock (the protein).

AutoDock, probably the most common molecular modeling application for protein docking, is a one of the more popular software package used by the drug research community. It played a role in developing some of the more successful HIV drugs on the market. Fortunately, AutoDock is freely available under the GNU General Public License.

The trick is to do these docking simulations on a grand scale. Thanks to the power of modern HPC machines, millions of compounds can now be screened against a protein in a reasonable amount of time. In truth, that timeframe is dependent upon how many cores you can put to the task. For a typical medium-sized cluster that a drug company might have in-house, it would take several weeks to screen just a few thousand compounds against one target protein. To reach a more interactive workflow, you need a something approaching a petascale supercomputer.

But not necessarily an actual supercomputer. Compute clouds have turned out to be very suitable for this type of embarrassing parallel application. For example, in a recent test with 50,000 cores on Amazon’s cloud (provisioned by Cycle Computing), software was able to screen 21 million compounds against a protein target in less than three hours.

Real supercomputers work too. At Oak Ridge National Lab (ORNL), researchers there used 50,000 cores of Jaguar to screen about 10 million drug candidates in less than a day. Jeremy C. Smith, director of the Center for Molecular Biophysics at ORNL, believes his type level of virtual screening is the most cost-effective approach to turbo-charge the drug pipeline. But the real utility of the supercomputing approach, says Smith, is that it can also be used to screen out drugs with toxic side effects.

Toxicity is often hard to detect until it comes time to do clinical trials, the most expensive and time-consuming phase of drug development. Worse yet, sometimes toxicity is not discovered until after the drug has been approved and released into the wild. So identifying these compounds early has the potential to save lots of money, not to mention lives. As Smith says, “If drug candidates are going to fail, you want them to fail fast, fail cheap.”

At the molecular level, toxicity is caused by a drug binding to the wrong protein, one that is actually needed by the body, rather than just selectively binding to the protein causing the condition. The problem is humans have about a thousand proteins, so every potential compound needs to be checked against each one. When you’re working with millions of drug candidates, the job becomes overwhelming, even for the petaflop supercomputers of today. To support the toxicity problem, you’ll need an exascale machine, says Smith.

Besides screening for toxicity, the same exascale setup can be used to repurpose existing drugs for other medical conditions. That is, the drug docking software could use approved drugs as the starting point and try to match them against various target proteins know to cause disease. Right now, drug repurposing is typically discovered on a trial-and-error basis, but the increasing number of compounds that are now in this multiple-use category suggests this could be rich new area of drug discovery.

In any case, sheer compute power is not the complete answer. For starters, the software has to be scaled up to the level of the hardware, and on an exascale machine, that hardware is more than likely going to be based on heterogenous processors. But since the problem is easily parallelized (each docking operation can be performed independently of one another), at least the scaling aspect should be relatively easy to overcome.

The larger problem is that the molecular modeling software itself is imperfect. Unlike a true lock and key, proteins are dynamic structures, and the action of binding to a molecule changes their shape. Therefore, physics simulation is also required to get a more precise match.

AutoDock, for example, is only able to provide a crude match between drug and protein. To get higher fidelity docking, more compute-intensive algorithms are required. Researchers, like those at ORNL, often resort to more precise molecular dynamics codes after getting performing a crude screening run with AutoDock.

None of this is a guarantee that virtual docking on exascale machines is going to launch a golden age of drugs. It’s possible that researchers will discover that there are just a handful of small molecule compounds that actually exhibit both disease efficacy and are non-toxic. But Smith believes this approach is full of promise. “This is the way to design drugs since this mirrors the way nature works,” he says.

Subscribe to HPCwire's Weekly Update!

Be the most informed person in the room! Stay ahead of the tech trends with industy updates delivered to you every week!

PRACEdays Reflects Europe’s HPC Commitment

May 25, 2017

More than 250 attendees and participants came together for PRACEdays17 in Barcelona last week, part of the European HPC Summit Week 2017, held May 15-19 at t Read more…

By Tiffany Trader

Russian Researchers Claim First Quantum-Safe Blockchain

May 25, 2017

The Russian Quantum Center today announced it has overcome the threat of quantum cryptography by creating the first quantum-safe blockchain, securing cryptocurr Read more…

By Doug Black

Google Debuts TPU v2 and will Add to Google Cloud

May 25, 2017

Not long after stirring attention in the deep learning/AI community by revealing the details of its Tensor Processing Unit (TPU), Google last week announced the Read more…

By John Russell

Nvidia CEO Predicts AI ‘Cambrian Explosion’

May 25, 2017

The processing power and cloud access to developer tools used to train machine-learning models are making artificial intelligence ubiquitous across computing pl Read more…

By George Leopold

HPE Extreme Performance Solutions

Exploring the Three Models of Remote Visualization

The explosion of data and advancement of digital technologies are dramatically changing the way many companies do business. With the help of high performance computing (HPC) solutions and data analytics platforms, manufacturers are developing products faster, healthcare providers are improving patient care, and energy companies are improving planning, exploration, and production. Read more…

PGAS Use will Rise on New H/W Trends, Says Reinders

May 25, 2017

If you have not already tried using PGAS, it is time to consider adding PGAS to the programming techniques you know. Partitioned Global Array Space, commonly kn Read more…

By James Reinders

Exascale Escapes 2018 Budget Axe; Rest of Science Suffers

May 23, 2017

President Trump's proposed $4.1 trillion FY 2018 budget is good for U.S. exascale computing development, but grim for the rest of science and technology spend Read more…

By Tiffany Trader

Hedge Funds (with Supercomputing help) Rank First Among Investors

May 22, 2017

In case you didn’t know, The Quants Run Wall Street Now, or so says a headline in today’s Wall Street Journal. Quant-run hedge funds now control the largest Read more…

By John Russell

IBM, D-Wave Report Quantum Computing Advances

May 18, 2017

IBM said this week it has built and tested a pair of quantum computing processors, including a prototype of a commercial version. That progress follows an an Read more…

By George Leopold

PRACEdays Reflects Europe’s HPC Commitment

May 25, 2017

More than 250 attendees and participants came together for PRACEdays17 in Barcelona last week, part of the European HPC Summit Week 2017, held May 15-19 at t Read more…

By Tiffany Trader

PGAS Use will Rise on New H/W Trends, Says Reinders

May 25, 2017

If you have not already tried using PGAS, it is time to consider adding PGAS to the programming techniques you know. Partitioned Global Array Space, commonly kn Read more…

By James Reinders

Exascale Escapes 2018 Budget Axe; Rest of Science Suffers

May 23, 2017

President Trump's proposed $4.1 trillion FY 2018 budget is good for U.S. exascale computing development, but grim for the rest of science and technology spend Read more…

By Tiffany Trader

Cray Offers Supercomputing as a Service, Targets Biotechs First

May 16, 2017

Leading supercomputer vendor Cray and datacenter/cloud provider the Markley Group today announced plans to jointly deliver supercomputing as a service. The init Read more…

By John Russell

HPE’s Memory-centric The Machine Coming into View, Opens ARMs to 3rd-party Developers

May 16, 2017

Announced three years ago, HPE’s The Machine is said to be the largest R&D program in the venerable company’s history, one that could be progressing tow Read more…

By Doug Black

What’s Up with Hyperion as It Transitions From IDC?

May 15, 2017

If you’re wondering what’s happening with Hyperion Research – formerly the IDC HPC group – apparently you are not alone, says Steve Conway, now senior V Read more…

By John Russell

Nvidia’s Mammoth Volta GPU Aims High for AI, HPC

May 10, 2017

At Nvidia's GPU Technology Conference (GTC17) in San Jose, Calif., this morning, CEO Jensen Huang announced the company's much-anticipated Volta architecture a Read more…

By Tiffany Trader

HPE Launches Servers, Services, and Collaboration at GTC

May 10, 2017

Hewlett Packard Enterprise (HPE) today launched a new liquid cooled GPU-driven Apollo platform based on SGI ICE architecture, a new collaboration with NVIDIA, a Read more…

By John Russell

Quantum Bits: D-Wave and VW; Google Quantum Lab; IBM Expands Access

March 21, 2017

For a technology that’s usually characterized as far off and in a distant galaxy, quantum computing has been steadily picking up steam. Just how close real-wo Read more…

By John Russell

Trump Budget Targets NIH, DOE, and EPA; No Mention of NSF

March 16, 2017

President Trump’s proposed U.S. fiscal 2018 budget issued today sharply cuts science spending while bolstering military spending as he promised during the cam Read more…

By John Russell

Google Pulls Back the Covers on Its First Machine Learning Chip

April 6, 2017

This week Google released a report detailing the design and performance characteristics of the Tensor Processing Unit (TPU), its custom ASIC for the inference Read more…

By Tiffany Trader

HPC Compiler Company PathScale Seeks Life Raft

March 23, 2017

HPCwire has learned that HPC compiler company PathScale has fallen on difficult times and is asking the community for help or actively seeking a buyer for its a Read more…

By Tiffany Trader

CPU-based Visualization Positions for Exascale Supercomputing

March 16, 2017

Since our first formal product releases of OSPRay and OpenSWR libraries in 2016, CPU-based Software Defined Visualization (SDVis) has achieved wide-spread adopt Read more…

By Jim Jeffers, Principal Engineer and Engineering Leader, Intel

Nvidia Responds to Google TPU Benchmarking

April 10, 2017

Last week, Google reported that its custom ASIC Tensor Processing Unit (TPU) was 15-30x faster for inferencing workloads than Nvidia's K80 GPU (see our coverage Read more…

By Tiffany Trader

Nvidia’s Mammoth Volta GPU Aims High for AI, HPC

May 10, 2017

At Nvidia's GPU Technology Conference (GTC17) in San Jose, Calif., this morning, CEO Jensen Huang announced the company's much-anticipated Volta architecture a Read more…

By Tiffany Trader

TSUBAME3.0 Points to Future HPE Pascal-NVLink-OPA Server

February 17, 2017

Since our initial coverage of the TSUBAME3.0 supercomputer yesterday, more details have come to light on this innovative project. Of particular interest is a ne Read more…

By Tiffany Trader

Leading Solution Providers

Facebook Open Sources Caffe2; Nvidia, Intel Rush to Optimize

April 18, 2017

From its F8 developer conference in San Jose, Calif., today, Facebook announced Caffe2, a new open-source, cross-platform framework for deep learning. Caffe2 is Read more…

By Tiffany Trader

Tokyo Tech’s TSUBAME3.0 Will Be First HPE-SGI Super

February 16, 2017

In a press event Friday afternoon local time in Japan, Tokyo Institute of Technology (Tokyo Tech) announced its plans for the TSUBAME3.0 supercomputer, which w Read more…

By Tiffany Trader

Is Liquid Cooling Ready to Go Mainstream?

February 13, 2017

Lost in the frenzy of SC16 was a substantial rise in the number of vendors showing server oriented liquid cooling technologies. Three decades ago liquid cooling Read more…

By Steve Campbell

MIT Mathematician Spins Up 220,000-Core Google Compute Cluster

April 21, 2017

On Thursday, Google announced that MIT math professor and computational number theorist Andrew V. Sutherland had set a record for the largest Google Compute Eng Read more…

By Tiffany Trader

US Supercomputing Leaders Tackle the China Question

March 15, 2017

As China continues to prove its supercomputing mettle via the Top500 list and the forward march of its ambitious plans to stand up an exascale machine by 2020, Read more…

By Tiffany Trader

HPC Technique Propels Deep Learning at Scale

February 21, 2017

Researchers from Baidu's Silicon Valley AI Lab (SVAIL) have adapted a well-known HPC communication technique to boost the speed and scale of their neural networ Read more…

By Tiffany Trader

DOE Supercomputer Achieves Record 45-Qubit Quantum Simulation

April 13, 2017

In order to simulate larger and larger quantum systems and usher in an age of "quantum supremacy," researchers are stretching the limits of today's most advance Read more…

By Tiffany Trader

Knights Landing Processor with Omni-Path Makes Cloud Debut

April 18, 2017

HPC cloud specialist Rescale is partnering with Intel and HPC resource provider R Systems to offer first-ever cloud access to Xeon Phi "Knights Landing" process Read more…

By Tiffany Trader

  • arrow
  • Click Here for More Headlines
  • arrow
Share This